Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Relationship Between Single-Nucleotide Polymorphisms of Tumor Necrosis Factor Alpha, Interleukin-10, Factor II and Factor V with Risk of Inhibitor Development in Patients with Severe Hemophilia A.

Souri S, Dadashizadeh G, Dorgalaleh A, Tabibian S, Keramati MR, Alizadeh S, Hosseini MS, Zaker F, Shams M.

Cardiovasc Hematol Disord Drug Targets. 2019 Feb 6. doi: 10.2174/1871529X19666190206152315. [Epub ahead of print]

PMID:
30727925
2.

A Unique Factor XIII Mutation in Southeastern Iran with an Unexpectedly High Prevalence: Khash Factor XIII.

Dorgalaleh A, Tabibian S, Shams M, Majid G, Naderi M, Casini A, Tavasoli B, Gheidishiran M, Daneshi M, Safa M.

Semin Thromb Hemost. 2019 Feb;45(1):43-49. doi: 10.1055/s-0038-1676580. Epub 2019 Jan 10. Review.

PMID:
30630205
3.

Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients.

Shams M, Dorgalaleh A, Safarian N, Emami AH, Zaker F, Tabibian S, Managhchi MR, Faranoush M, Tabatabaei T, Satari S, Rezvani MR.

Blood Coagul Fibrinolysis. 2019 Jan;30(1):24-28. doi: 10.1097/MBC.0000000000000791.

PMID:
30585836
4.

Molecular diagnosis of factor XIII deficiency, data from comprehensive coagulation laboratory in Iran.

Gheidishahran M, Dorgalaleh A, Tabibian S, Shams M, Sanei Moghaddam E, Khosravi S, Naderi M, Kahraze S, Lotfi F, Kazeme A, Safa M.

Blood Coagul Fibrinolysis. 2018 Jan;29(1):87-91. doi: 10.1097/MBC.0000000000000679.

PMID:
29095761
5.

Intracranial hemorrhage in congenital bleeding disorders.

Tabibian S, Motlagh H, Naderi M, Dorgalaleh A.

Blood Coagul Fibrinolysis. 2018 Jan;29(1):1-11. doi: 10.1097/MBC.0000000000000660. Review.

PMID:
28901996
6.

Intracranial Hemorrhage: A Devastating Outcome of Congenital Bleeding Disorders-Prevalence, Diagnosis, and Management, with a Special Focus on Congenital Factor XIII Deficiency.

Alavi SER, Jalalvand M, Assadollahi V, Tabibian S, Dorgalaleh A.

Semin Thromb Hemost. 2018 Apr;44(3):267-275. doi: 10.1055/s-0037-1604109. Epub 2017 Sep 12. Review.

PMID:
28898896
7.

Inherited Platelet Function Disorders (IPFDs).

Dorgalaleh A, Tabibian S, Shamsizadeh M.

Clin Lab. 2017 Jan 1;63(1):1-13. doi: 10.7754/Clin.Lab.2016.160607. Review.

PMID:
28164499
8.

Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran.

Dorgalaleh A, Alavi SE, Tabibian S, Soori S, Moradi E, Bamedi T, Asadi M, Jalalvand M, Shamsizadeh M.

Hematology. 2017 May;22(4):224-230. doi: 10.1080/10245332.2016.1263007. Epub 2016 Nov 28. Review.

PMID:
27894217
9.

Molecular Basis of Congenital Factor XIII Deficiency in Iran.

Dorgalaleh A, Assadollahi V, Tabibian S, Shamsizadeh M.

Clin Appl Thromb Hemost. 2018 Mar;24(2):210-216. doi: 10.1177/1076029616680473. Epub 2016 Nov 23.

PMID:
27879471
10.

Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran.

Naderi M, Tabibian S, Menegatti M, Kalantar E, Kazemi A, Zaker F, Dorgalaleh A.

Blood Coagul Fibrinolysis. 2016 Dec;27(8):933-935.

PMID:
26836269
11.

Comparison of 2 Methods of Clot Solubility Testing in Detection of Factor XIII Deficiency.

Dorgalaleh A, Tabibian S, Assadollahi V, Shamsizadeh M, Zareban I, Soori S, Daneshi M.

Lab Med. 2016 Nov;47(4):283-285. Epub 2016 Aug 13.

PMID:
27522062
12.

Childhood acute lymphoblastic leukemia: refusal and abandonmentof treatment in the southeast of Iran.

Naderi M, Esmaeili Reykande S, Tabibian S, Alizadeh S, Dorgalaleh A, Shamsizadeh M.

Turk J Med Sci. 2016 Apr 19;46(3):706-11. doi: 10.3906/sag-1412-42.

PMID:
27513245
13.

Laboratory Diagnosis of Factor XIII Deficiency in Developing Countries: An Iranian Experience.

Dorgalaleh A, Tabibian S, Shams M, Tavasoli B, Gheidishahran M, Shamsizadeh M.

Lab Med. 2016 Aug;47(3):220-6. doi: 10.1093/labmed/lmw021. Epub 2016 Jun 26.

14.

Diagnosis of factor XIII deficiency.

Dorgalaleh A, Tabibian S, Hosseini MS, Farshi Y, Roshanzamir F, Naderi M, Kazemi A, Zaker F, Aghideh AN, Shamsizadeh M.

Hematology. 2016 Aug;21(7):430-9. doi: 10.1080/10245332.2015.1101975. Epub 2016 Mar 30. Review.

PMID:
27077776
15.

Miscarriage and recurrent miscarriage in patients with congenital factor V deficiency: a report of six cases in Iran.

Naderi M, Tabibian S, Shamsizadeh M, Dorgalaleh A.

Int J Hematol. 2016 Jun;103(6):673-5. doi: 10.1007/s12185-016-1981-7. Epub 2016 Mar 15.

PMID:
26980222
16.

Spectrum of factor X gene mutations in Iranian patients with congenital factor X deficiency.

Dorgalaleh A, Zaker F, Tabibian S, Alizadeh S, Dorgalele S, Hosseini S, Shamsizadeh M.

Blood Coagul Fibrinolysis. 2016 Apr;27(3):324-7. doi: 10.1097/MBC.0000000000000435. Review.

PMID:
26891460
17.

Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran.

Naderi M, Reykande SE, Dorgalaleh A, Alizadeh S, Tabibian S, Einollahi N, Moghaddam EM.

Blood Coagul Fibrinolysis. 2016 Jan;27(1):97-100. doi: 10.1097/MBC.0000000000000374. Erratum in: Blood Coagul Fibrinolysis. 2016 Mar;27(2):234.

PMID:
26703985
18.

Guidelines for laboratory diagnosis of factor XIII deficiency.

Dorgalaleh A, Tabibian S, Hosseini S, Shamsizadeh M.

Blood Coagul Fibrinolysis. 2016 Jun;27(4):361-4. doi: 10.1097/MBC.0000000000000459.

PMID:
26588445
19.

Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian population.

Hosseini S, Kalantar E, Hosseini MS, Tabibian S, Shamsizadeh M, Dorgalaleh A.

Thromb J. 2015 Nov 10;13:35. doi: 10.1186/s12959-015-0064-y. eCollection 2015.

20.

First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran.

Hosseini S, Dorgalaleh A, Bamedi T, Tavakol K, Tabibian S, Naderi M, Alizadeh S, Varmaghani B, Shamsizadeh M, Rahimizadeh A, Ebrahimi S.

Blood Coagul Fibrinolysis. 2015 Dec;26(8):908-11. doi: 10.1097/MBC.0000000000000358.

PMID:
26226252
21.

Effect of Social Factors on the Highest Global Incidence of Congenital Factor XIII Deficiency in Southeast of Iran.

Naderi M, Alizadeh S, Tabibian S, Hosseini S, Varmaghani B, Shamsizadeh M, Dorgalaleh A.

Arch Iran Med. 2015 May;18(5):331. No abstract available.

PMID:
26155604
22.

Inhibition of factor XIIa, a new approach in management of thrombosis.

Dorgalaleh A, Hosseini MS, Mobaraki RN, Alizadeh S, Hosseini S, Tabibian S, Shamsizadeh M, Moghaddam ES, Khosravi S, Rahimizadeh A.

Ann Transl Med. 2015 May;3(Suppl 1):S20. doi: 10.3978/j.issn.2305-5839.2015.02.14. No abstract available.

23.

Factor XIII deficiency in Iran: a comprehensive review of the literature.

Dorgalaleh A, Naderi M, Hosseini MS, Alizadeh S, Hosseini S, Tabibian S, Eshghi P.

Semin Thromb Hemost. 2015 Apr;41(3):323-9. doi: 10.1055/s-0034-1395350. Epub 2015 Jan 23. Review.

PMID:
25615432
24.

Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency.

Naderi M, Younesi MR, Dorgalaleh A, Alizadeh S, Kazemi A, Tabibian S.

Hematology. 2015 Sep;20(8):487-492. doi: 10.1179/1607845414Y.0000000226. Epub 2014 Dec 29.

PMID:
25544259
25.

Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disorders.

Naderi M, Tabibian S, Alizadeh S, Hosseini S, Zaker F, Bamedi T, Shamsizadeh M, Dorgalaleh A.

Acta Haematol. 2015;133(2):148-54. doi: 10.1159/000363598. Epub 2014 Sep 26.

PMID:
25277779
26.

Public Health Problems related to factor V deficiency in southeast of Iran.

Naderi M, Tabibian S, Dorgalaleh A, Kashani Kahtib Z, Alizadeh S.

Med J Islam Repub Iran. 2014 May 7;28:27. eCollection 2014. No abstract available.

27.

Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.

Naderi M, Dorgalaleh A, Alizadeh S, Tabibian S, Hosseini S, Shamsizadeh M, Bamedi T.

Int J Hematol. 2014 Nov;100(5):443-9. doi: 10.1007/s12185-014-1664-1. Epub 2014 Sep 18.

PMID:
25230816
28.

Congenital combined deficiency of coagulation factors: a study of seven patients.

Naderi M, Tabibian S, Hosseini MS, Alizadeh S, Hosseini S, Shamsizadeh M, Dorgalaleh A.

Blood Coagul Fibrinolysis. 2015 Jan;26(1):59-62. doi: 10.1097/MBC.0000000000000180.

PMID:
25215615
29.

Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases.

Naderi M, Alizadeh S, Kazemi A, Tabibian S, Zaker F, Bamedi T, Kashani Khatib Z, Dorgalaleh A.

Hematology. 2015 Mar;20(2):112-8. doi: 10.1179/1607845414Y.0000000172. Epub 2014 Jul 7.

PMID:
25001244
30.

Anemia and thrombocytopenia in acute and chronic renal failure.

Dorgalaleh A, Mahmudi M, Tabibian S, Khatib ZK, Tamaddon GH, Moghaddam ES, Bamedi T, Alizadeh S, Moradi E.

Int J Hematol Oncol Stem Cell Res. 2013;7(4):34-9.

31.

A prospective study of tubular dysfunction in pediatric patients with Beta thalassemia major receiving deferasirox.

Naderi M, Sadeghi-Bojd S, Valeshabad AK, Jahantigh A, Alizadeh S, Dorgalaleh A, Tabibian S, Bamedi T.

Pediatr Hematol Oncol. 2013 Nov;30(8):748-54. doi: 10.3109/08880018.2013.823470.

PMID:
24134694

Supplemental Content

Loading ...
Support Center